Abbott Study Links CGM Use to Lower Mortality in Type 2 Diabetes
Abbott's Libre CGM use was associated with nearly 50% fewer acute Type 2 diabetes-related hospitalizations in one study.
Abbott's Libre CGM use was associated with nearly 50% fewer acute Type 2 diabetes-related hospitalizations in one study.